Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel XR for MDD with comorbid GAD
NCT00868374Phase 3Terminated
- Sponsor
- Keming Gao
- Start
- Jun 2008
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in major depressive disorder (MDD), generalized anxiety disorder (GAD), sponsored by Keming Gao. Started Jun 2008; status: terminated.
02
Drugs
quetiapine
03
Conditions
major depressive disorder (MDD)generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00868374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00868374.